
Wockhardt Investor Relations Material
Latest events

Q1 25/26
8 Aug, 2025

Q4 24/25
29 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Wockhardt Limited
Access all reports
Wockhardt Limited is a pharmaceutical and biotechnology company engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations, biopharmaceuticals, and active pharmaceutical ingredients (APIs). The company operates across therapeutic areas including anti-infectives, cardiology, neurology, and diabetes care. It has manufacturing and research facilities that comply with international regulatory standards and serves both domestic and global markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
WOCKPHARMA
Country
🇮🇳 India